Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Unaudited Condensed Consolidated Statements of Cash Flows
Net loss	$ (8,835,000)	$ (14,144,000)
Adjustment to reconcile net loss to net cash used in operating activities:
Stock based compensation - services	752,000	469,000
Stock based compensation - prepaid	0	342,000
Stock issued from equity incentive plan	(19,000)	22,000
Gain from settlement of accounts payable	0	(26,000)
Gain from extinguishment of debt	(741,000)	0
Change in fair value of contingent share consideration	(947,000)	5,658,000
Change in fair value of convertible promissory notes	(1,112,000)	0
Depreciation and amortization	2,584,000	277,000
Bad debt expenses	41,000	31,000
Recovery of bad debt expense	(221,000)	0
Loss on disposal of property, plant and equipment	41,000	0
Inventory reserve for obsolescence	(113,000)	5,000
Change of fair value in derivative liabilities	0	(88,000)
Fair value of vested stock options and restricted stock	2,527,000	1,652,000
Change in operating assets and liabilities:
Accounts receivable	(25,000)	65,000
Inventory	(398,000)	(77,000)
Prepaid expenses and other assets	1,042,000	227,000
Other assets	(25,000)	0
Accounts payable	139,000	550,000
Accrued expenses	3,126,000	63,000
Finance lease payable	(9,000)	(8,000)
Contract liabilities	(383,000)	(140,000)
License fees	(80,000)	(8,000)
Cash used in operating activities	(2,656,000)	(5,130,000)
Cash flows from investing activities
Investment in company	0	(250,000)
Purchase of intangible assets	(68,000)	(11,000)
Acquisition of property and equipment, net	(32,000)	(642,000)
Purchase of note receivable	(200,000)	(550,000)
Collection of note receivable	200,000	0
Cash used in investing activities	(100,000)	(1,453,000)
Cash flows from financing activities
Proceeds from exercise of warrants	0	1,417,000
Proceeds from notes payable	1,000,000	2,299,000
Proceeds from related party payable	400,000	0
Repayment of loans payable	(205,000)	(127,000)
Cash provided by financing activities	1,195,000	3,589,000
Net decrease in cash and cash equivalents	(1,561,000)	(2,994,000)
Cash and cash equivalents, beginning of year	1,725,000	4,096,000
Cash and cash equivalents, end of period	164,000	1,102,000
Cash paid for interest and income taxes:
Interest	102,000	3,000
Income taxes	0	0
Non-cash investing and financing activities:
Common stock issued for conversion of promissory notes and accrued interest	2,881,000	0
Common stock issued for settlement of earnout liabilities from the acquisiton of Chemistry Holdings, Inc	$ 0	$ 21,701,000